To make things a little less confusing, we’re here with all the info you need about popular weight loss med Mounjaro.

A study published in JAMA Network, by the Case Western Reserve University examined about 15,11,637 eligible participants with ...

New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an ...

Scholar Rock Holding Corporation (NASDAQ:SRRK) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Scholar Rock ...

While tirzepatide has been on the market to treat type 2 diabetes under the name Mounjaro, Zepbound was just FDA approved for weight loss and most health insurances don’t cover it as a result ...

How tirzepatide works for weight loss Tirzepatide is a type of medication known as a GLP-1 agonist, which means it mimics a naturally-occurring hormone in the body called a peptide to influence a ...

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN), a rare eye condition ...

An injection drug known as tirzepatide, already approved by the FDA for treating Type 2 diabetes, is likely to gain approval for weight loss treatment this year. Here's what to know.

The primary candidates for tirzepatide weight loss are adults who are classified as obese (BMI ≥30) or overweight (BMI ≥27) with one or more weight-related health conditions such as ...

Tirzepatide and injectable semaglutide were associated with the greatest weight loss after a year of treatment among several GLP-1 receptor agonists, a recent study showed.“Despite being the ...

Tirzepatide is sold under the brand names Mounjaro and Zepbound. This diabetes and weight loss drug can come with a high price tag. So, how much does tirzepatide cost?